Line 2: |
Line 2: |
| | | |
| ==Description== | | ==Description== |
− | ==Signalment==
| + | *Caused by a [[Paramyxoviridae#Canine Distemper Virus (CDV)|morbillivirus]] |
− | ==Diagnosis==
| + | *[[Nasal Cavity Inflammatory - Pathology#Infectious causes of rhinitis|Rhinitis]] |
− | ===Clinical Signs===
| + | *Although many organs can be affected by CDV, a relatively constant feature is the respiratory signs which occur in varying severity |
− | ===Laboratory Tests===
| + | *A syndrome of catharral oculonasal discharge, [[Nasopharynx Inflammatory - Pathology#Infectious causes of pharyngitis|pharyngitis]] and [[Bronchi and Bronchioles Inflammatory - Pathology#Infectious causes of bronchitis or bronchiolitis|bronchitis]] is relatively common in the initial stages |
− | ===Diagnostic Imaging===
| + | *Since one of the primary sites of action of this virus is lymphoid tissue, the resultant immunosuppression -> predisposition to secondary bacterial infection |
− | ===Pathology===
| + | *May cause [[Lungs Inflammatory - Pathology#Interstitial pneumonia|interstitial pneumonia]] where [[Degenerations and Infiltrations - Pathology#Cellular Inclusions|inclusions]] are found within alveolar macrophages |
− | ==Treatment==
| + | *Gross pathology: |
− | ==Prognosis==
| + | **Oedematous lungs, diffuse interstitial pneumonia |
− | ==Links==
| + | *Micro pathology: |
− | ==References==
| + | **Necrosis of pneumocytes, necrotising bronchiolitis, alveolar oedema, thickening of alveolar walls and type II pneumocyte hyperplasia |
| | | |
− | Also known as CDV
| + | Aerosol infection |
− | ====Hosts====
| |
− | *Dogs, ferrets, seals, lions, mink
| |
− | *Has been a major pathogen of dogs prior to vaccination
| |
− | ====Pathogenesis====
| |
− | *Aerosol infection
| |
| *Infects alveolar [[Macrophages|macrophages]] or [[Oropharynx - Pathology|oropharynx]] | | *Infects alveolar [[Macrophages|macrophages]] or [[Oropharynx - Pathology|oropharynx]] |
| *Multiplies in the bronchial and other lymph nodes, infects [[Monocytes|monocytes]] and dendritic cells | | *Multiplies in the bronchial and other lymph nodes, infects [[Monocytes|monocytes]] and dendritic cells |
Line 40: |
Line 35: |
| *Involvement of central nervous system generally results in death | | *Involvement of central nervous system generally results in death |
| | | |
− | ====Diagnosis==== | + | *Can contribute to [[Canine Infectious Tracheobronchitis|Infectious Canine Tracheitis]] |
| + | *May be involved in [[Pancreatitis, Chronic Interstitial|chronic interstitial pancreatitis]] |
| + | *May cause [[Bones Developmental - Pathology#Retention of elongated primary trabeculae|growth retardation lattice]] |
| + | *May also trigger latent [[Toxoplasma|Toxoplasmosis]] due to suppressing effect on lymphoid tissue |
| + | ==Signalment== |
| + | |
| + | *Dogs, ferrets, seals, lions, mink |
| + | *Has been a major pathogen of dogs prior to vaccination |
| + | ==Diagnosis== |
| *May present as series of infections | | *May present as series of infections |
| *'''Immunocytochemistry''' of inclusion bodies | | *'''Immunocytochemistry''' of inclusion bodies |
Line 46: |
Line 49: |
| **Inclusions persist longest in the brain (may be intranuclear) and the alveolar macrophages | | **Inclusions persist longest in the brain (may be intranuclear) and the alveolar macrophages |
| **Sections of fixed bronchial tissue, lung, macrophages, bladder may be used or nasal or conjunctival epithelium from live animals | | **Sections of fixed bronchial tissue, lung, macrophages, bladder may be used or nasal or conjunctival epithelium from live animals |
− | *Giant cells may be seen in the alveoli | + | *Giant cells may be seen in the alveol |
− | ====Control==== | + | ===Clinical Signs=== |
| + | ===Laboratory Tests=== |
| + | ===Diagnostic Imaging=== |
| + | ===Pathology=== |
| + | ==Treatment== |
| + | |
| *Live attenuated virus vaccines given at 10 and 12 weeks of age | | *Live attenuated virus vaccines given at 10 and 12 weeks of age |
| **Some now given at 7 and 10 weeks to allow socialisation | | **Some now given at 7 and 10 weeks to allow socialisation |
| *Homeopathic vaccines do not work | | *Homeopathic vaccines do not work |
| *Live attenuated vaccines may kill some wildlife therefore '''Iscom vaccine''' is used in seal sanctuaries | | *Live attenuated vaccines may kill some wildlife therefore '''Iscom vaccine''' is used in seal sanctuaries |
− | ====Secondary Concerns==== | + | ==Prognosis== |
− | *Can contribute to [[Canine Infectious Tracheobronchitis|Infectious Canine Tracheitis]]
| + | ==Links== |
− | *May be involved in [[Pancreatitis, Chronic Interstitial|chronic interstitial pancreatitis]]
| + | ==References== |
− | *May cause [[Bones Developmental - Pathology#Retention of elongated primary trabeculae|growth retardation lattice]]
| |
− | *May also trigger latent [[Toxoplasma|Toxoplasmosis]] due to suppressing effect on lymphoid tissue
| |
− | | |
− | | |
− | | |
− | ===Canine distemper===
| |
− | | |
− | *Caused by a [[Paramyxoviridae#Canine Distemper Virus (CDV)|morbillivirus]]
| |
− | *[[Nasal Cavity Inflammatory - Pathology#Infectious causes of rhinitis|Rhinitis]]
| |
− | *Although many organs can be affected by CDV, a relatively constant feature is the respiratory signs which occur in varying severity
| |
− | *A syndrome of catharral oculonasal discharge, [[Nasopharynx Inflammatory - Pathology#Infectious causes of pharyngitis|pharyngitis]] and [[Bronchi and Bronchioles Inflammatory - Pathology#Infectious causes of bronchitis or bronchiolitis|bronchitis]] is relatively common in the initial stages
| |
− | *Since one of the primary sites of action of this virus is lymphoid tissue, the resultant immunosuppression -> predisposition to secondary bacterial infection
| |
− | *May cause [[Lungs Inflammatory - Pathology#Interstitial pneumonia|interstitial pneumonia]] where [[Degenerations and Infiltrations - Pathology#Cellular Inclusions|inclusions]] are found within alveolar macrophages
| |
− | *Gross pathology:
| |
− | **Oedematous lungs, diffuse interstitial pneumonia
| |
− | *Micro pathology:
| |
− | **Necrosis of pneumocytes, necrotising bronchiolitis, alveolar oedema, thickening of alveolar walls and type II pneumocyte hyperplasia
| |
− | | |
− | | |
| | | |
| | | |